http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20637135

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 807
issn 0028-4793
1533-4406
issueIdentifier 9
pageRange 800-807
publicationName The New England journal of medicine
startingPage 800
bibliographicCitation Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL; Adefovir Dipivoxil 438 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med. 2003 Feb 27;348(9):800–7. doi: 10.1056/nejmoa021812. PMID: 12606734.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5999b8cc238115410be4ab468ce9d931
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06f62192f572fb07b3730ec10a8992c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50c47eb8c33e5e58e1241bfdff5ae0a5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b4ba21e91e730ebb7382e7429855843
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64f9c138fcea5a42f93e8c7a63302bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5febe16eacb3537210f91309a26b3527
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68b8ee9e7ece219beb8e7b739121c72e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca0b3d463e123bf6801959174831f48f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_577a1b935a62b6763cdb1c84764ddf7f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ce388d6accdc4333d45a12afb2c0ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9bb46d95248b0db77f5ada057421927
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c47e45a023b3ace2078e9aa6dbe71064
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43d46540ddd1541b4b03256dc52913ba
date 2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/12606734
https://doi.org/10.1056/nejmoa021812
isPartOf https://portal.issn.org/resource/ISSN/1533-4406
https://portal.issn.org/resource/ISSN/0028-4793
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
discusses http://id.nlm.nih.gov/mesh/M0278180
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0000620
http://id.nlm.nih.gov/mesh/M0571031
http://id.nlm.nih.gov/mesh/M0010216
http://id.nlm.nih.gov/mesh/M0006695
http://id.nlm.nih.gov/mesh/M0000347
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D063065
http://id.nlm.nih.gov/mesh/D000998Q000627
http://id.nlm.nih.gov/mesh/D019694Q000188
http://id.nlm.nih.gov/mesh/D000225Q000031
http://id.nlm.nih.gov/mesh/D000225Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008099Q000473
http://id.nlm.nih.gov/mesh/D000225Q000009
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000410Q000097
http://id.nlm.nih.gov/mesh/D019694Q000821
http://id.nlm.nih.gov/mesh/D006515Q000302
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D001706
http://id.nlm.nih.gov/mesh/D019694Q000473
http://id.nlm.nih.gov/mesh/D006513
http://id.nlm.nih.gov/mesh/D006515Q000235
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D004279Q000097
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000998Q000009
http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204

Total number of triples: 71.